Clinical Trial Matching & GO Molecular Tumor Board

GenomOncology's Clinical Trial Matching and GO Molecular Tumor Board solutions are purpose-built for oncology teams seeking to accelerate patient enrollment, expand access to precision medicine, and ensure no trial opportunity is missed. Designed for clinical oncologists, tumor boards, trial coordinators, cancer center research operations, CROs, and pharmaceutical sponsors, these tools combine AI-powered matching, collaborative case review, and robust clinical decision support into an integrated precision oncology workflow.

Trusted by 50+ leading healthcare institutions, GenomOncology delivers scalable, seamless precision medicine capabilities that connect genomic and clinical data to actionable treatment and trial options at the point of care.

Real-Time Patient-Trial Matching

• Continuous monitoring of patient genomic and clinical data
• Instant alerts triggered the moment eligibility criteria are met
• Full, wild-type, and partial match detection
• Ranked results ordered by match confidence

Comprehensive Trial Coverage

• Access to 15,000+ active oncology trials
• Support for institution-specific trials alongside public databases
• Automated trial updates sourced from ClinicalTrials.gov
• Custom curation services available for specialized needs

Sophisticated Matching Logic

• Granular biomarker filtering covering specific variants, fusions, and copy number variations (CNVs)
• Complex eligibility criteria support including demographics, prior treatments, and comorbidities
• Exclusion criteria processing to surface only genuinely eligible candidates
• Semantic understanding of clinical concepts for accurate interpretation

Workflow Integration

• Embedded directly within GO Molecular Tumor Board
• EHR integration via GO Connect
• Configurable notification preferences for clinical teams
• Dedicated trial coordinator dashboards

Cohort Analytics and Feasibility

• Population-level trial eligibility analysis across patient cohorts
• Enrollment forecasting to support planning
• Site feasibility assessments for research operations
• Recruitment planning tools to optimize trial activation

GO Molecular Tumor Board — Automated Case Preparation

• Variant significance pre-analysis completed before case review
• Therapy recommendations generated based on genomic findings
• Clinical trial matching integrated for each individual case
• Evidence summaries drawn from literature and curated databases

GO Molecular Tumor Board — Presentation Generation

• Auto-generated slide decks ready for tumor board review
• Customizable presentation templates to match institutional preferences
• Real-time annotation capabilities during live meetings
• Decision capture and structured documentation of outcomes

GO Molecular Tumor Board — Real-Time Collaboration

• Multi-user simultaneous case access
• Discussion threading to organize clinical commentary
• Vote and consensus tracking across multidisciplinary team members
• Meeting minutes export for records and compliance

GO Molecular Tumor Board — Clinical Decision Support

• FDA-approved therapy suggestions aligned to genomic findings
• NCCN guideline alignment for standard-of-care recommendations
• Off-label therapy evidence surfaced for consideration
• Clinical trial options presented and prioritized within the review workflow

GO Molecular Tumor Board — Outcomes Tracking

• Treatment recommendations logged for each case
• Follow-up and patient response tracking over time
• Aggregate metrics available for precision oncology program evaluation

GO Precision Oncology API Suite

• Trial matching API for embedding eligibility logic into custom applications
• Variant annotation API for genomic data interpretation
• Therapy recommendation API to surface treatment options programmatically
• Patient cohort query API for population-level research and analytics
• Custom integration support for IT teams, research informatics groups, and EHR integration projects

GenomOncology integrates with major EHR platforms including MEDITECH Expanse Genomics and has established partnerships with institutions such as OHSU Knight Diagnostics Lab and WeTrials, demonstrating a strong track record of enabling precision oncology access across academic medical centers, comprehensive cancer centers, and health systems of all sizes.